HEMISPHERIAN AS
Organisation
Private Company
Norway
OSLO
,
Norway
HEMISPHERIAN AS
2
Projects
0
Interests Submitted
898354540
PIC
898354540
Reference
Projects
chemGLIO
Chemical synthesis of a new drug family to treat glioblastoma multiforme (GBM), the highest global unmet need in oncology
H2020
Signed
H2020-INNOSUP-2020-02
CureGLIO
Clinical validation of GLIX1: a small molecule that targets epigenetic changes in cancer cells to treat glioblastoma multiforme (GBM), the highest global unmet need in oncology.
HORIZON
Signed
HORIZON-EIC-2022-ACCELERATOR-01
Work Programmes
H2020
HORIZON
Additional Information
VAT:
NO925333409MVA
Validation Status:
31042522